MedicGo
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
Metadata
Journalkidney international8.945Date
2020 Jun 04
4 months ago
Type
Letter
Case Report
Volume
2020-08 / 98 : 508-509
Author
Gautier-Vargas G 1, Baldacini C 2, Benotmane I 3, Keller N 2, Perrin P 4, Moulin B 4, Caillard S 4
Affiliation
  • 2. Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • 3. Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
  • 4. Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France; Institut national de la santé et de la recherche médical, immunorhumatologie moléculaire unité mixte de recherche-S 1109, Strasbourg, France.
Doi
PMIDMESH
Aged
Antibodies, Monoclonal, Humanized
Betacoronavirus
Coronavirus Infections
Cytokine Release Syndrome
Humans
Kidney Transplantation
Male
Pandemics
Pneumonia, Viral
Fav
Like
Download
Share
Export
Cite
8.9
Kidney Intkidney international
Metadata
LocationUnited States
FromELSEVIER SCIENCE INC

No Data

© 2017 - 2020 Medicgo
Powered by some medical students